From ThoughtSpot 2019: National Diabetes Prevention Program

July 31, 2019 | Pamela Youngberg

The conceptual framework for a new diabetes prevention program went through a series of pilots across the country in 2016, each coming to the same conclusion: it works. Over the typical course of a 15-month program, healthcare cost savings of more than $2k per participant were achieved. The pilot programs, many of which were run through local YMCAs, provided enough proof of concept to warrant the launch of the National Diabetes Prevention Program which supplies education, coaching, and support to patients. Once those patient outcomes are met, with its built-in opportunity for profit, the program is a boon to pharmacists, who are often untapped resources in the fight against the disease.

In the “National Diabetes Prevention Program: An Opportunity for Pharmacy” presentation at ThoughtSpot 2019, co-presenters Bill Popomaronis (NCPA), Ashley Keller (STRAND Clinical Technologies), and Donna Avant, RPh (Ehrhardt Pharmacy), identified a few tips for taking advantage of the program in the community pharmacy setting.

Continue reading →

The Weekly Roundup: Continued State Action on Step Therapy (7.19.19)

July 19, 2019 | Pamela Youngberg

In May, CMS announced its final rule allowing step therapy for Medicare Part B drugs. Although various interests pushed back, the move had clearly been signaled, pushing legislators across the country into motion to counter—or at least clarify—the plans to mandate the approach. Almost two dozen states thus far have addressed step therapy—or as opponents like to refer to it, the “fail-first policy”—at their respective legislatures. This includes last year’s efforts in our home state of Minnesota and the bill signed this month in Wisconsin that seeks to provide for a more clear patient appeal process.

Continue reading →

}